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ABSTRACT
The purpose of this study is to examine the usefulness of the Geriatric 
Learning and Memory Battery (G-LAMB) for assessing learning and memory 
performance in persons with Alzheimer’s Disease (AD). Individuals with AD 
often perform so poorly on standard memory tests that assessing learning and 
memory strengths and weaknesses or tracking changes over time is, at best, 
difficult. The G-LAMB is a recently developed test composed of a Paragraph 
and a simple Figure and was designed specifically to help assess and monitor 
verbal and visuospatial learning and memory performance in people already 
diagnosed with cognitive deficits. One group for whom this test may have 
particular utility are people with AD who experience both verbal and visuospatial 
learning and memory changes and who can live for extended periods of time 
post-diagnosis. Alongside efforts to identify an etiology and cure for AD, there is 
an emerging emphasis on quality of life issues for both those living with AD and 
their caregivers. In this context, the ability to assess deficits, prescribe treatment 
and then monitor changes becomes critical. In the current study, the G-LAMB 
verbal (Paragraph) and visuospatial (Figure) subtests were administered to 
individuals with mild and moderate stages of AD. Findings suggest that the 
G-LAMB is a useful tool for assessing learning and memory performance in 
those with AD. First, the scores of individuals with Mild AD are high enough to 
allow one to monitor changes in learning and memory, at least into the moderate 
stages of the disease. Second, it is possible to differentiate the performance 
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INTRODUCTION
Alzheimer’s Disease (AD) is a dementia; that is, an acquired, persistent 
impairment in mental functioning affecting memory, language and visuospatial 
skills along with emotion, personality and judgement. Unlike reversible 
dementias which sometimes accompany thyroid problems, infections, depression 
and inappropriate medication use, AD is an irreversible dementia with no known 
cause or cure. Although, as recently as 1991, only 28% of Canadians were 
familiar with AD, today, over 50% of Canadians know someone witti Alzheimer’s 
Disease. Currently, more than 253,000 Canadians are suffering from AD with 
the number expected to triple by the year 2030 (Canadian Study of Health and 
Aging, 1994a).
With such a major impact on the Canadian population, it is not surprising 
that an increasing amount of research on Alzheimer’s Disease is taking place.
In the past, most research was directed at finding the cause and cure for AD. 
However, a shift has taken place with a newer and increasingly critical area of 
investigation now being treatment and management of the disease (i.e., 
improving quality of life). This is particularly important given the fact that 
individuals with AD currently live an average of 8 years, but as long as 20 years 
or more, after diagnosis (Barclay, Zemcov, Blass & Sansone, 1985; Cummings & 
Benson, 1992; Treves et al., 1986).
The following research addresses one aspect of treatment; in particular, 
the need for a memory test designed specifically to assess and track memory 
changes in individuals already diagnosed with AD. Prior to elaborating the
G-LAMB Performance 2
specifics of the research, background information on dementia and, specifically 






Dementia is an acquired (i.e., not congenital) persistent impairment of 
intelle tual performance with deficits in at least three of the following areas of 
mental functioning: memory, language, visuospatial skills, emotion or 
personality, and cognition (e.g., abstraction and judgement) (Cummings,
Benson, & LoVerme, 1980). Some dementias can be reversible such as those 
caused by metabolic problems (e.g., hypothyroidism), inappropriate medication 
use, infections, environmental toxins, and depression. Because treatment is 
possible in the case of reversible dementias, it is critical that the source of a 
suspected dementia be identified as quickly as possible. Other dementias such 
as AD, vascular dementia (VaD), Parkinson's Disease, Huntington's Disease and 
Pick's Disease have no known cure and are characterized as irreversible 
(Cummings & Benson, 1992). AD is the most common type of irreversible 
dementia accounting for as much as 65% of total cases (Canadian Study of 
Health and Aging, 1994a; Terry & Katzman, 1983).
Alzheimer's Disease
Alzheimer's Disease is a progressive, degenerative, and irreversible brain 
disorder that impairs a person's ability to think, remember, make decisions, 
understand and use language. AD becomes more prevalent as people age, 
generally affecting those 65 years and older, although people in their thirties, 
forties and fifties can acquire the disease. A person with AD, especially in the
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early stage, may feel afraid, angry or frustrated because he/she Is no longer able 
to do all the things that were possible before the onset of the disease. As the 
disease progresses, the ability to live independently is lost and, because there is 
no known cure, death inevitably follows. Although much research is underway to 
uncover the etiology of AD, there is currently no definitive diagnostic test that can 
be administered while the patient is still living. A definite AD diagnosis can be 
made only after death utilizing information provided by an autopsy. Such 
autopsies reveal changes in the brain that include unusual knots or tangles in 
nen/e cells (called neurofibrillary tangles), clusters of debris from broken down 
nerve cells (called senile plaques) and a general shrinkage in brain tissue due to 
the destruction of so many nerve cells (Alzheimer Society of Canada, 1991 ; 
Cummings & Benson, 1992).
The etiology or cause of AD is also unknown. A number of possible 
causes have been suggested including chemical changes in the brain, a virus, 
environmental toxins, aluminum poisoning and genetic factors. None of these 
possible causes has been definitively confirmed (Cummings & Benson, 1992). 
However, there are some identified risk factors such as increased age, family 
history of AD, presence of Down's syndrome, and prior head injury. Recent 
research (Canadian Study of Health and Aging, 1994b) has also found 
preliminary associations between risk of Alzheimer’s Disease and occupational 
exposure to glues, fertilizers and pesticides. The same study revealed that 
higher levels of education were a protective factor but further study is required as 
education may not be the actual source of the protection. For example, it may
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be that a good diet reduces the risk of getting AO and that people with a higher 
education can afford to eat better foods than those with a lower education level. 
NINCDS-ADRDA Clinical Diagnostic Criteria
The fact that AD has no known cause or cure and that it can only be 
confirmed at autopsy poses substantial difficulties in diagnosis. Until the mid- 
1980’s, 20 percent or more of cases thought to t>e AD were found, at autopsy, to 
be other diseases. In addition, lack of uniformity in diagnostic criteria caused 
problems when comparing the results of research conducted by different 
investigators. In order to address this situation, a working group on the diagnosis 
of Alzheimer’s Disease, established by the National Institute of Neurological and 
Communicative Disorders and Strokes (NINCDS) and the Alzheimer’s Disease 
and Related Disorders Association (ADRDA), produced some standard clinical 
diagnostic criteria for AD (McKhann et al., 1984). The NINCDS-ADRDA criteria 
for pmbable AD include: dementia established by clinical examination and 
documented by a mental status screening test and confirmed by 
neuropsychological tests; deficits in two or more areas of cognition; progressive 
worsening of memory and other cognitive functions; no disturbance of 
consciousness; onset between ages 40 and 90, most often after age 65; and, 
absence of systematic disorders or other brain diseases that in and of 
themselves could account for the progressive deficits in memory and cognition. 
This probable diagnosis can be supported by: progressive deterioration of 
specific cognitive functions such as language, motor skills, and perception; 
impaired activities of daily living and altered patterns of behaviour, family history
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of similar disorders; and, laboratory results indicating normal lumbar puncture 
and EEG or signs of cerebral atrophy on a CT scan with progression 
documented by serial obsenrations.
In arriving at a probable AD diagnosis, perhaps one of the most difficult 
tasks is to rule out any other disorders that may account for the deficits in 
memory and cognition. Of particular importance are screening for depression, 
fronto-temporai dementia and vascular dementia, which can also cause cognitive 
impairment and may be confused with Alzheimer’s Disease. Other conditions to 
consider include psychiatric disorders involving delusions and hallucinations and 
diseases such as Huntington’s and Parkinson’s (Cummings & Benson, 1992). In 
addition to meeting the probable AD criteria, researchers should also specify 
features that may differentiate subtypes of AD such as familial occurrence, onset 
before age 65, presence of Down’s syndrome and coexistence of other 
conditions such as Parkinson’s disease (McKhann et al., 1984).
A de W e  Alzheimer’s diagnosis requires meeting the above clinical 
criteria for probable AD as well as histopathologic evidence obtained through 
autopsy or biopsy. Clearly, a definite diagnosis cannot be employed in this study 
but, in order to establish with as much certainty as possible that participants in 
the current study do have AD, the NINCDS-ADRDA criteria and guidelines for 
probable AD will be closely adhered to. As a result of employing the NINCDS- 
ADRDA criteria, misdiagnosis is now less than 10% (Miller, 1997). However, 
there is one notable shortcoming in relying on these criteria: individuals at early 
stages of AD are often missed (Cahn et a!., 1997; Feldman, 1998; Tuokko,
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Kristjansson & Miller, 1995).
Learning in Alzheimer’s Disease
The process of leaming involves the acquisition, consolidation and 
storage of information prior to remembering. Even at the early stages of AD, 
leaming is impaired (Huppert, 1994; La Rue, 1992). Problems exist in both 
encoding and consolidation. In particular, individuals with AD show a failure to 
learn, even over repeated trials and, thus, exhibit a flat leaming curve (Butters, 
Delis & Lucus, 1995). The rate of leaming is slower, less information is acquired 
and the level of retention is lower than in healthy older adults. These deficits 
appear to occur in both visual and verbal leaming (Welsh, Butters, Hughes,
Mohs & Heyman, 1991).
In contrast to healthy older adults, those with AD benefit little from 
encoding enhancement activities during the leaming process (Knopman & 
Ryberg, 1989). For example, having the opportunity to learn a word list by first 
making up sentences about the words provides a semantic context (i.e., 
meaning) that aids leaming in normal older persons (La Rue, 1992). However, in 
AD, such leaming aids appear to be of little value. Further, the leaming style of 
persons with AD can be characterized as passive as exemplified by the tendency 
to recall items from the end of a word list (Delis, Kramer, Kaplan, & Ober, 1987). 
Rapid loss of information, even when retrieval demands are minimal, suggests 
deficits in information storage (Zee, 1993).
Memory in Alzheimer’s Disease
Memory deficits are also apparent in very early stages of AD and, along
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with the connected leaming problems, are one of the first indications to the 
individual with AD, and to their families, that something is wrong.
Free recall, cued recall and recognition. In assessing memory, three 
types of procedures are potentially employed: free recall, cued recall and 
recognition. Free recall requires the individual to remember previously acquired 
information completely unaided (e.g., “Draw the picture you saw 10 minutes 
ago.”), thus, placing high demands on search and retrieval processes. Cued 
recall utilizes the same search and retrieval processes as free recall but the 
individual is provided with a cue about the information to be remembered (e.g., 
“Remember the picture of the farmyard you saw 10 minutes ago? Please draw it 
now.”). Finally, recognition is the least demanding memory task requiring only a 
familiarity judgement (e.g., “Pick out the picture you saw 10 minutes ago from 
among these 4 pictures.”).
As with healthy older adults, persons with AD find recall (both free and 
cued) more difficult than recognition and free recall more difficult than cued 
recall. In the early stages of AD, memory deficits are most noticeable with free 
recall tasks, but AD patients also score below normative levels on both cued 
recall and recognition tasks (Huppert, 1994; Incaizi, Capparella, Gemma, Marra 
& Carbonin, 1995; La Rue, 1992). The deficits AD patients exhibit with recall 
and recognition tasks (in comparison to age-related norms) are present in both 
verbal and visuospatial memory (Sahakian et al., 1988).
Verbal memory. Tests of verbal memory are relatively more “pure” in form 
than visuospatial memory tests which often include visual, spatial and
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constructional components that can t)e hard to tease apart. Typical verbal 
memory tasks would include leaming and remembering word lists, paired word 
associates (e.g., fniit/apple) and short stories. In persons with AD, it is semantic 
memory deficits (acquiring and remembering an item based on its meaning) that 
appear to have a major impact on verbal memory. If one cannot encode the 
meaning of a word, it is likely that remembering the word will be more difficult. 
The source of semantic deficiencies in AD patients is not yet identified. Is 
verbal memory loss due primarily to encoding, consolidation or retrieval 
problems? Are encoding deficits caused by attentional or semantic 
deficiencies? In addition to these unanswered questions, another problem is the 
large amount of variation in the verbal memory abilities of those with AD. This 
range of capability, whether due to premorbid ability, the stage of the disease or 
neuropsychological heterogeneity (indicating possible subtypes of AD), makes it 
difficult to identify a clear cut profile of verbal memory deficits in persons with AD 
(Strite, Massman, Cooke & Doody, 1997).
Visuospatial memonr. Deficits in visuospatial memory are generally 
acknowledged as one of the earliest signs of Alzheimer’s Disease (Robinson- 
Whelan, 1992; Sahgal et al., 1992). Although clinically helpful, there remain 
many questions about what, precisely, visuospatial memory tests are measuring. 
Unlike verbal memory, where relatively pure measures have been developed 
(e.g. word lists and short stories), investigating visuospatial memory appears to 
be more complex. Typical visuospatial memory tasks include visual reproduction 
(copying and remembering a design or group of designs) or visuai paired
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associates (e.g., matching a design with a colour). Pictures of identifiable 
objects can also be used but tend to encourage verbal encoding and, therefore, 
confound an assessment of verbal and visuospatial memory. Geometric figures 
which have been designed using components that are not easily encoded 
verbally or semantically have been relatively successful in dealing with this 
problem. However, difficulty teasing out the visuo-perceptive component (i.e., 
applying meaning to a visual array), the visuospatial component (i.e., the ability 
to process spatial relationships in visual information) and the visuoconstructional 
component (the ability to construct a visually presented item) of visuospatial 
memory remains a problem (Ricker, Keenan, & Jacobson, 1994). In fact, it has 
been suggested that performance on visuospatial memory tests by AO patients 
may reflect more on visual-perceptual, constructional and executive abilities than 
on memory (Taylor, 1994).
Keeping these concerns in mind, it is perhaps not surprising that there is 
some equivocation amongst researchers as to precisely which components (i.e. 
visual, spatial or constructional) are affected in mild AD. Robinson-Whelan 
(1992) suggests that it is visual memory that is affected early in the disease with 
visuospatial and visuoconstructional abilities affected later on. However, Kaskie 
and Storandt (1995) propose that there are visuospatial deficits even in very mild 
AD. In their research, Ricker, Keenan & Jacobson (1994) have determined that 
the relationship between visuospatial abilities and memory performance is more 
robust in clinical AD samples than in non-demented older persons. One 
explanation presented is that the greater amount of variability among demented
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patients facilitates the detection of relationships that can be obscured in the 
normal population where performance is more homogeneous.
The heterogeneity of memory deficits in persons with AD makes it difficult 
to identify a single visuospatial (or verbal) memory profile. For example, 
Massman et al. (1993) have presented a visuospatial memory profile with three 
subgroups of AD patients including: 1. those who performed better on verbal 
tests; 2. those who performed better on visuospatial tests; and 3. those who had 
equivalent performance on each. More recently, Strite, Massman, Cooke and 
Doody (1997) have confirmed asymmetry (individual differences) in verbal and 
visuoconstructional deficits across all stages of AD. Huppert (1994) suggests 
that, rather than being AD profiles, the apparent subgroups could simply 
represent predisorder differences. Whatever the origins of possible subgroups 
within an AD population, it would appear that this heterogeneity should be taken 
into account when assessing verbal and visuospatial memory rather than simply 
evaluating the mean memory level of a given sample.
Rate of forgetting. Rate of forgetting refers to the rate at which 
information is lost independent of the amount or rate at which it is acquired. In 
other words, the fact that one individual may learn more words on the list than 
another or may learn a word list at a faster rate than another, does not 
necessarily have any impact on the rate of forgetting. The baseline for 
determining forgetting rates is the amount of information learned by the end of 
training (i.e., leaming trials). Starting from this point, another measurement is 
taken, after a specified time delay, to determine how much information has been
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lost. The rate at which an individual has forgotten learned material can then be 
calculated. Subsequent measurements can also be taken after increasingly 
longer delays and further rates of forgetting can be determined.
In the literature, there are a variety of methods used to determine rates of 
forgetting. One method is to ensure that both groups have acquired the same 
amount of information at the conclusion of the leaming trials (i.e., 80-90% of the 
material) but without attaining the maximum score. Measurements of information 
forgotten are then taken at one or more delay intervals with rates of forgetting 
calculated in terms of absolute number of items lost. The logic for not reaching 
maximum score is that, at maximum, it will not be possible to differentiate 
between those who have overleamed the material and those who have just 
learned it at the end of the last acquisition trial.
Rates of forgetting can also be evaluated by looking at relative decline in 
the number of items remembered over time (i.e., comparing slopes). In this 
method, groups can start at different levels of acquisition because the 
researcher’s interest is in whether the difference between the groups stays the 
same or varies significantly across different delay intervals. Another approach, 
deriving difference scores, can also be used. Difference scores are calculated 
by subtracting a measurement taken after a delay inten/al from one taken at a 
the end of acquisition (i.e., the last leaming trial). These difference scores are 
then compared to determine if there is a statistically significant difference 
between the difference scores of each group.
Finally, another derived score known as a savings score (or percent
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retained) can be calculated by dividing the delay score by the final acquisition 
score and multiplying by 100. There is a problem that arises with savings scores 
that is of particular concern when assessing persons with low acquisition scores 
such as may be the case in Alzheimer's disease. Specifically, when raw scores 
in one group are substantially lower than those in the second group (after 
completion of leaming trials), the percentage saved (after a delay interval) in 
each group can appear to be markedly different even if the number of items 
forgotten is, in fact, the same.
With regard to Alzheimer’s Disease, the findings regarding rates of 
forgetting are equivocal. Research in which forgetting rates have been 
measured after relatively longer intervals (i.e., a minimum of 10 minutes and 
usually longer) has found no difference between the forgetting rates of AD 
patients and normals (Knopman, 1991 ; Kopelman, 1985). Most of these studies 
were conducted using recognition memory tasks (Huppert & Piercy, 1978) in 
which the subjects need only make a familiarity judgement. However, studies 
using the Huppert and Piercy method, but with delay inten/als under 10 minutes, 
found sharp increases in forgetting immediately after the last leaming trial (La 
Rue, 1992). Similarly, other research using recall rather than recognition has 
also shown a sharp decline in recollection immediately following leaming 
(Butters, Delis & Lucus, 1995). These findings, taken as a whole, suggest that 
there may be acquisition and/or consolidation deficits rather than a retrieval 
problem in Alzheimer’s Disease. That is, if there is a sharp decline in what is 
remembered Immediately after leaming has taken place, it would seem that the
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problem Is less likely to be an inability to locate and retrieve the information from 
memory but rather that the item to be remembered did not make it into memory 
in the first place.
In terms of evaluating rates of forgetting, an additional problem has arisen 
using recall tasks with demented subjects. Specifically, when tests are too 
difficult, initial levels of leaming are extremely low (showing floor effects), thus 
making it difficult to evaluate either difference or savings scores in those with AD. 
Therefore, a memory test simple enough that the cognitively impaired do not 
"bottom out" would be helpful in reaching a more definitive conclusion regarding 
rates of forgetting in AD.
Problems with Current Tests of Memory
Use of current memon/ tests with older adults. Most currently available 
memory tests have not been designed to address the assessment needs of older 
adults. Rather, most tests (e.g., Wechsler Memory Scale - Revised, Benton 
Visual Retention Test, Califomia Verbal Leaming Test) were created with the 
objective of evaluating memory performance over the entire adult lifespan.
These tests are usually administered under standardized conditions with 
everyone, regardless of age, given the same instructions and time limits. While 
this may seem the best approach in terms of standardization and test reliability, 
there are instances, such as with older adults, where this methodology tends to 
decrease the validity of test results. For example, because standardized 
memory tests do not take into account the slower processing and leaming 
abilities of older people (Powell, 1979; Satthouse, 1982), their memory abilities
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can be seriously underestimated.
Often memory tests are too difficult and older adults become anxious and 
frustrated because they do not perform well. This may. in turn, decrease the 
individual's motivation causing them to expend less effort during testing or to 
become noncompliant. As a result, the older adult may learn less information 
which makes the interpretation of retention levels problematic. In fact, an older 
adult’s performance on some memory tests may be so low that monitoring 
retention and change overtime is very difficult. These problems are further 
magnified with a cognitively impaired population (Hubley, 1995; La Rue, 1992).
Use of current memon/ tests for persons with Alzheimer's Disease. 
Persons with AD tend to score poorly on traditional learning and memory tests. 
The result is floor-effects" where scores are so uniformly low that it is difficult to 
measure further decline or to differentiate one individual’s score from another. 
For example, if persons with AD score an average of 2 out of a possible 20 
points on a memory test, it is difficult to measure further deterioration because 
there is no room on the scale to account for additional decline. In other words, 
there is a lack of range or differentiation of scores because everyone does 
poorly. This does not, however, mean that there are not differences between 
individuals taking the test. Nor does it mean that further memory changes do not 
take place over time. It simply means that the testing instrument being used is 
not sensitive to these differences or changes.
The bottoming-out of memory scores has practical implications for the 
care and treatment of those with AD. Because clinicians may be unable to
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provide meaningful learning and memory scores beyond the fact that AD 
individuals perform very poorly, test results afford little assistance to those 
determining treatment protocols and making ongoing lifestyle and treatment 
decisions.
Research suggests that individuals with dementia of the Alzheimer’s type 
often score so poorly on standard memory tests that tracking the course of 
memory changes is simply not possible (Esiinger, Damasio, Benton & Van Allen, 
1985; LaRue, D’Elia, Clark, Spar & Jarvik, 1986; Welsh, Butters, Hughes, Mohs 
& Heyman, 1991). Even those individuals with mild Alzheimer’s Disease (AD) 
can exhibit severe memory deficits such as remembering fewer than two items in 
immediate recall of a short story (Butters, Granholm, Salmon, Grant, & Wolfe, 
1987), reproducing only two of ten geometric designs and show almost no 
evidence of learning difficult, abstract, or unrelated word pairs such as 
spirit/interest (LaRue et al., 1986). In addition, low scores and an essentially flat 
leaming curve have been reported when administering the Rey-Auditory Verbal 
Learning Test (R-AVLT) and the Rey-Osterrieth Complex Figure Design (R-0 
CFD) to early stage AD patients (Bigler, Rosa, Schultz, Hall & Harris, 1989).
It can, therefore, be seen that the use of standard memory tests for AD 
patients results in scores at the lower extremity of the test range and, generally, 
does not allow for discrimination among different degrees of dementia nor for 
tracking memory changes overtime (Blackburn & Tyrer, 1985; Miller, 1981). 
Taking all of these potential shortcomings of standard memory tests into 
account, it is clear that there is a need for the design and testing of a memory
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The current research focuses on the appropriateness of a recently 
developed test, the Geriatric Leaming and Memory Battery (G-LAMB; Hubley, 
1995), for an Alzheimer’s population. The G-LAMB, which Is composed of two 
relatively easier tasks than standard memory tests. Is specifically designed to 
help monitor verbal and visuospatlal memory In people already diagnosed with 
cognitive deficits. In particular, the G-LAMB Is expected to allow for the range of 
scores missing from the performance of cognltlvely-lmpalred persons on many 
standardized memory tests and, because of this. Is meant to permit 
differentiation among different levels of Impaired performance. The G-LAMB Is 
composed of a simple story (Paragraph) for assessing verbal memory and a 
simple geometric design (Figure) for assessing visuospatlal memory (see Figure 
1, next page). Stories and designs are commonly used to assess memory. 
However, the G-LAMB Figure Is much simpler than the traditionally used Rey- 
Osterrieth Complex Figure and the Paragraph Is made even simpler than most 
by Including a self-read procedure In Its administration. This provides the 
Individual with the opportunity to use other memory strategies beyond those 
available when the tester only reads the story aloud.
The G-LAMB has already been nonned on 180 community-dwelling adults 
aged 55-85 years (Hubley, 1995). With a healthy community sample of older 
adults, the level of leaming on the G-LAMB met the expected goals -  that Is, at
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Figure 1.
G-LAMB Paragraph and Figure
On Sunday, Jane and her five-year-old brother went 
to a circus In Paris. At 4:15, when they were buying their 
tickets. It started to rain. As they were running for the 
animal tent, the boy tripped and cut his leg. A clown 




(D1995 Anita M. Hubley
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least 90% of material was learned by tfie last acquisition trial. Such high 
acquisition levels in a cognitively intact sample are expected to allow for a 
relatively "high" enough level of performance (and range) in persons with 
cognitive deficits and, in particular those with AD, that clinicians and researchers 
will be able to more easily differentiate among different levels of performance 
and track type and rate of changes in performance over time using this test.
Being able to identify changes in memory capacity (usually declines, but 
sometimes improvements) is not only important in determining a person’s 
strengths and weaknesses in both verbal and visuospatlal memory but is also 
invaluable in designing treatment regimes based on these strengths and 
weaknesses. For example, if a person does particularly poorly on the Figure, a 
decision could be made that reorganizing the furniture of his or her living 
quarters or planning a move to a new home might not be appropriate because 
the capability to remember a new layout is compromised. At the same time, 
verbal memory may remain relatively stable and so the present ability to give the 
person short verbal instructions about something (e.g., an exercise to be 
repeated during physiotherapy, information about an appointment later in the 
day) may be preserved. Such infomnation can assist caregivers, both in the 
home and in care facilities, to design their inten/entions more effectively by 
placing more emphasis on a person's strengths and less on their weaknesses. 
As a result, individuals with cognitive impairments can be afforded a better 
quality of life.
In terms of clinical application, it is expected that the G-LAMB will provide
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a brref measure of verbal and visuospatlal memory that will permit a wide 
enough range of scores to obtain a sensitive measure of level of performance 
and change over time among individuals with Alzheimer’s disease. Furthermore, 
the G-LAMB should allow clinicians to obtain useful information about the 
strengths, weaknesses and relative rate of decline in an individual’s verbal and 
visuospatlal memory. This information should assist in placement decisions as 
well as evaluating, designing or modifying approaches to any treatment or 
therapy (such as physiotherapy, occupational therapy, speech therapy, and 
phamnacological intenrentions) and generally assist in setting realistic 
expectations about the individual’s abilities at any given point.
The specific objectives of the proposed research are: (1) to determine 
whether the average performance on the G-LAMB of persons who have mild to 
moderate Alzheimer’s Disease (AD) will be high enough to permit assessment of 
change (usually declines) overtime, and show enough range to be sensitive to 
differences among cognitively impaired individuals, (2) to compare verbal and 
visuospatlal memory perfomnance of individuals with mild to moderate AD with 
the norms for healthy community-dwelling older adults, and (3) to examine the 
relationship of the G-LAMB subtests to similar tests within an AD sample. 
Although designed as a tracking test, the current research on the G-LAMB 
involves a one-time test only in order to determine i; participants will score high 
enough to allow for the range necessary for assessment over time. The tracking 
of memory performance overtime demands the use of multiple geometric figures 
and paragraphs of equivalent levels of difficulty so that practice effects from
G-LAMB Performance 22
using the same materials will not be a confounding factor in the scores obtained. 
However, multiple equivalent test materials will not be developed until the utility 
of the existing G-LAMB subtests can be shown.
Hvpotheses
Total AD Group versus normative sample.
1. The leaming. memory, and visuospatlal constructional performance of 
persons with AD on both the verbal (Paragraph) and visuospatlal (Figure) 
G-LAMB subtests is predicted to be significantly lower than the norms derived 
from a healthy population of older adults. Rate of forgetting on both G-LAMB 
subtests is expected to be significantly higher for persons with AD than for the 
normative group.
Mild AD Group versus Moderate AD Group.
1. It is expected that the average scores of participants with mild levels of 
cognitive impairment on both the verbal (Paragraph) and visuospatlal (Figure) G- 
LAMB subtests will be high enough (i.e., will not show floor effects) that there will 
be room to identify changes in verbal and/or visuospatlal leaming and memory 
over time.
2. The leaming and memory performance of persons with Mild AD on 
both G-LAMB subtests, as well as visuospatlal construction scores on the Figure, 
are predicted to be significantly higher than the performance of persons with 
Moderate AD. Rate of forgetting on both subtests is expected to be significantly 
higher for the Moderate AD group than for the Mild AD group.
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Relationship of G-LAMB subtests to similar tests within an AD sample.
1. Statistically significant, positive correlations are expected between the 
G-LAMB Paragraph and the other verbal tests administered (i.e., LAMB Word 
List B, Verbal Fluency (FAS and Animals) and the Boston Naming Test).
2. Statistically significant, positive correlations are expected between the 
G-LAMB Figure and the other visuospatial tests administered (i.e., LAMB Simple 
Figures and the Clock Test).
The following associations will also be examined, although no specific 
hypotheses are presented; (1) the relationship between performance on the G- 
LAMB Paragraph and Figure within an AD sample, and (2) the relationship of the 






Fourteen persons with Alzheimer’s Disease were selected to participate in 
the study on a volunteer basis. The Mild group included three men and four 
women whereas the Moderate group was composed entirely of women. Tables 
1 and 2 (see next page) provide additional demographic information on the Mild 
and Moderate groups, respectively. Informed consent was obtained from the 
participant and/or consen/ator as applicable (see Appendix A).
Norms. Normative data (Hubley, 1995) referenced throughout the study 
was based on a sample of 169' healthy, community-dwelling older adults (77 
men and 92 women) who ranged in age from 54 to 85 years (M = 69.7, SD = 
8.63). Education levels varied from 8 to 16 years (M = 12.3, ^  = 2.01) and 
Mini-Mental State Examination (MMSE) scores (Folstein, Folstein & McHugh, 
1975), which ranged from 25 to 30, were all above the accepted cut-off score of 
24.
Recruitment of clinical sample. Participants were recruited in Prince 
George and the surrounding area through a variety of methods (see Appendix 
8). Initially, local and regional Alzheimer organizations and care facilities were 
approached, in the latter case, facility staff approached the families of potential 
study participants first in order to obtain permission for the researcher to contact 
the family members directly (see Appendix C). Local and regional media
' Although the norms were originally derived from a sample of 180 healthy, older adults (see page 18), the 
normative sample for the current study included only those individuals within the age and education range 
of the AD sample; thus, n =  169.
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Table 1
Demographic Information for Mild AD group fn=7\
Variable Mean Std Deviation Range
Age 70.4 9.93 54 -80
Education 11.3 2.50 8 - 1 6
MMSE 27.7 1.60 25-30
GDS 6.9 4.10 2 - 1 2
Note. Education is reported in years; MMSE = Mini-Mental State Examination 
(max. score = 30; higher score = less likelihood of cognitive impairment); GDS = 
Geriatric Depression Scale (max. score = 30; higher score = greater severity of 
depression).
Table 2
Demographic infonnation for Moderate AD group fn=7^
Variable Mean Std Deviation Range
Age 84.3 7.95 72 -93
Education* 8.5 2.59 6 - 1 3
MMSE 21.4 1.72 19-23
GDS 8.6 3.87 5 - 1 4
Note. Education is reported in years; MMSE = Mini-Mental State Examination 
(max. score = 30; higher score = less likelihood of cognitive impairment); GDS = 
Geriatric Depression Scale (max. score = 30; higher score = greater severity of 
depression).
*n=6; a woman with no formal education (but who was home schooled) was 
excluded from the education calculation.
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coverage followed. In addition, research information and/or posters (see 
Appendices D and E, respectively) were delivered to physicians in an area 
bounded by Williams Lake in the south and Mackenzie in the north to McBride in 
the east and Bums Lake in the west. Pharmacists in Prince George, Quesnel 
and McBride were also contacted. A presentation was made to the Prince 
George Regional Hospital (PGRH) Research Review Committee as well as to 
the hospital's Psychiatric Outpatient Clinic staff. Study information was 
available in the PGRH emergency department and medical/geriatrics area. The 
Psychogeriatric Outreach Assessment Team, the Canadian Mental Health 
Association, and Home Support Services were provided with information about 
the study as well. Finally, local seniors’ organizations, including senior housing 
developments, were contacted. As a result, individuals from Prince George, Fort 
St. John, McBride and Quesnel participated in the study. Out of town subjects 
were tested in their own locales.
NINCDS-ADRDA Criteria
Study participants were required to meet the NINCDS-ADRDA criteria for 
probable AD (McKhann et al., 1984). NINCDS-ADRDA requirements include 
estimating the level of cognitive impairment, confirming deficits in memory and at 
least one other area of cognitive functioning and mling out other systemic 
disorders or brain disease. These requirements were assessed as follows:
1 ■ Estimation of cognitive impairment
a. The Mini-Mental State Examination (MMSE: Folstein et al., 1975) was 
administered in order to estimate the severity of overaii cognitive
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impairment. Based on research by Welsh, Butters, Hughes, Mohs & 
Heyman (1991) with an AD sample, mild impairment is defined as MMSE 
scores of 24 or greater with moderate impairment consisting of scores 
between 19 and 23. Scores of 14 to 18 indicate moderate/severe 
impairment and scores less than 14 are designated as severe impairment.
2. Deficits in two or more areas of cognitive functioning (one of which must be 
memorvi
Deficits in cognitive functioning were assessed as follows:
a. memory: delay trials for the Leaming and Memory Battery (LAMB) 
Word List B (Hubley,1995) and the LAMB Simple Figures (Schmidt & 
Tombaugh, 1995; Tombaugh & Schmidt, 1992);
b. visuospatial skills: copy trials for The Clock Test (Libon, Malamut, 
Swenson, Sands, & Cloud,1996; Rouleau, Salmon, Butters, Kennedy, & 
McGuire, 1992) and the LAMB Simple Figures (Schmidt & Tombaugh, 
1995; Tombaugh & Schmidt, 1992);
c. language skills: Boston Naming Test (Kaplan, Goodglass, & 
Weintraub, 1983) and the Verbal Fluency Task (FAS and Animals; 
Borkowski, Benton, & Spreen, 1967).
When assessing test performance, selecting the cut-off score necessary 
to meet the criteria for a cognitive deficit is a critical issue. In this context, one of 
the growing concerns of researchers studying the diagnosis and treatment of AD 
is how to detect and evaluate those individuals who are at a very early stage of 
the disease and for whom neuropsychological tests are often not sensitive
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enough to identify the disease (Cahn et al., 1997; Feldman, 1998; Tuokko et al.,
1995). This is of particular importance if early stage individuals are going to 
have the opportunity to benefit from new treatments (e.g., drugs such as 
Aricept). In this regard, the gold standard NINCDS-ADRDA criteria themselves 
may need refinement or supplementation in order to include individuals in the 
early stage of AD (Feldman, 1998). However, until other criteria are established 
or neuropsychological tests more sensitive to early signs of cognitive decline are 
developed, the NINCDS-ADRDA referents remain the accepted diagnostic tool 
for AD research. It is within this context that the more liberal one standard 
deviation below normal peer performance has been adopted in the current study 
as the appropriate cut-off to meet the NINCDS-ADRDA criteria for deficits in 
cognitive functioning (Rediess & Caine, 1996; Rissenberg & Glanzer, 1987).
3. Ruling out other svstemic disorder or brain disease 
In addition to studying charted patient histories, the following tests were 
administered in order to help rule out other systemic causes for patient 
symptoms:
a. The Revised Hachinski Ischemic Scale (Hachinski et al., 1975; Rosen, 
Terry, Fuld, Katzman, & Peck, 1980) was used to assess the likely 
presence of vascular dementia (i.e., dementia due to stroke or a series of 
small ischemic incidents). Individuals with a score of 3 or more were 
excluded from the study.
b. The Geriatric Depression Scale (Yesavaoe et al., 1983) was 
administered to screen for depression. Individuals in the depressed range
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(i.e., scores > 14) were excluded from the study.
Patient charts, supplemented by discussion with the physicians and families 
(and, where possible, the participants themselves), were used to verify 
progressive worsening of memory and other cognitive functioning, to identify any 
history of head injury resulting in loss of consciousness, to estimate the age of 
onset of dementia (which should be approximately 40 to 90 years), and to 
identify any prescribed medications. Individuals who were taking medications 
producing substantial sedative or cholinergic effects or who had a known history 
of neurological disease, psychiatric distress, or head injury were excluded from 
the study.
Meeting the Diagnostic Criteria
As a result of the wide range of recruitment methods employed, 65 
prospective participants, or their family members, contacted the Aging and 
Memory Laboratory regarding participation in the current study. It was then 
necessary to determine whether each potential subject met the previously 
outlined criteria.
A preliminary screening was conducted by telephone with each individual 
or family contact. The purpose of this initial contact was to identify and screen 
out individuals who were clearly not suitable candidates for the study. For 
example, some people indicated that they had no symptoms whatsoever but 
were concerned because there was a history of AD in their family. Others had 
been diagnosed with another type of cognitive impairment altogether (e.g., brain 
injury) but thought It would be similar enough to AD to warrant their participation
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in the research. These individuals (10 in total) were informed that they would not 
be appropriate participants for this particular study but were invited to have their 
names placed on a list for future research regarding memory and/or aging.
A medical and demographic information sheet and/or the Revised 
Hachinski Ischemic Scale were then completed for each of the 55 remaining 
prospective participants. Information was obtained from the individuals 
themselves (where possible), from family members, and from charts (for those 
living in care facilities). People were deemed ineligible if their medical and 
demographic history provided information that either ruled out a probable AD 
diagnosis or suggested a co-existing neurological condition (e.g., history of 
alcohol abuse or stroke), indicated severe perceptual problems (e.g., significant 
vision or hearing loss), revealed an advanced stage of AD with serious 
communication problems that would preclude testing, or suggested the need for 
testing in a language other than English. Once again, the 15 excluded 
individuals were approached regarding placement on a list of potential 
participants for future research. Thus, prior to beginning any formal testing, the 
potential sample size was reduced from 65 to 40.
The testing process was initiated with the remaining 40 participants. 
Fifteen of these individuals were unable to complete the testing regime either 
due to illness (n = 3) or because of their own unwillingness or inability to finish 
(n = 12). Therefore, 25 subjects completed the entire test battery. However, 
successful completion of all tests did not guarantee inclusion of an individual in 
the final research sample. In fact, tests other than the G-LAMB Paragraph and
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Figure were included in the study primarily in order to determine if participants 
met the NINCDS-ADRDA criteria for probable AD (McKhann et al., 1984) and, 
specifically, whether deficits in two or more areas of cognitive functioning 
(including memory) could be identified. Upon completion of test scoring, seven 
individuals were immediately excluded: two had elevated depression scores and 
five displayed no cognitive deficits.
The remaining 18 participants were divided into the following categories 
for further consideration:
1. mild: those with an MMSE score equal to or greater than 24 
accompanied by at least two areas of cognitive deficit;
2. moderate: those with an MMSE score of 19 to 23 inclusive 
accompanied by at least two areas of cognitive deficit;
3. moderate/severe: those with an MMSE score of 14 to 18 inclusive 
accompanied by at least two areas of cognitive deficit;
4. severe: those with an MMSE score less than 14 accompanied by 
at least two areas of cognitive deficit.
Figures 2 and 3 present performance on the leaming, memory and copy trials of 
the G-LAMB Paragraph and Figure respectively for each individual participant in 
the previously-mentioned categories .^
Although the study was focused primarily on those people with mild to 
moderate AD who clearly met the research criteria, two moderate/severe and two 
severe individuals were tested in order to evaluate the (lower) limits in the
'  Because the performance of the moderate/severe and severe groups cannot be easily differentiated, these 
groups are combined and labelled “severe” to improve visual clarity in Figures 2 and 3.
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potential utility of the G-LAMB. As Figures 2 and 3 indicate, the performance by 
individuals in the moderate/severe and severe groups show floor effects 
suggesting that the G-LAMB would not be particularly useful in differentiating 
these groups from each other or from the moderate group. Thus, these four 
individuals were also excluded from the final sample. Therefore, although the 
research began with 65 potential participants, the number of subjects meeting all 
the necessary criteria, and providing useful data with which to evaluate the 
G-LAMB, was 14: seven individuals with mild AD and seven individuals with 
moderate AOf.
Procedure
Study participants who met the study criteria were individually 
administered a series of cognitive and memory tests 1 1/2 hours in length. If 
participants found the testing too long for one sitting, it was divided into two 
shorter sessions. Testing occurred in several different locations including private 
resident rooms in care facilities, designated testing rooms in care facilities, in the 
homes of participants and, finally, in the Aging and Memory Laboratory at UNBC. 
In each environment, strict measures were taken to prevent outside interruptions 
to the testing procedure.
The sequence of test administration is of particular importance in this 
study. Not only are there the usual considerations required in order to 
accommodate delay intervals for those tests with delay trials but there is the
" This IS not an epidemiological study and thus no inference should be drawn regarding the incidence or 









Delay (fr) Delay (fr-Hec)
THais
Figure 2. Individual performance on G-LAMB Paragraph Trials for AD groups: 









added difficulty of testing a group tfiat may be unable to complete all of tfie tests 
or may require a second sitting. Because of tfiese potential problems, tests fiave 
been sequenced not only to provide appropriate delay intervals but also to 
ensure tfiat tfie tests most critical to tfie success of tfiis researcfi are completed 
as early as possible in tfie session. Witfi tfiis rationale in mind, tfie following test 
order was employed:
1. Mini-Mental State Examination
2. Geriatric Depression Scale
3. G-LAMB Paragrapfi (leaming - 2 trials)
4. G-LAMB Figure (leaming - 3 trials)
5. G-LAMB Paragrapfi (memory and recognition)
6. The Verbal Fluency Task (FAS and Animals)
7. G-LAMB Figure (memory and copy)
8. Hubley Depression Scale (filler task)
9. LAMB Simple Figures (leaming - 3 trials)
10. LAMB Word List B (leaming - 5 trials)
11. The Clock Test
12. LAMB Simple Figures (memory and copy)
13. LAMB Word List B (memory and recognition)
14. Boston Naming Test
Note: The Revised Hachinski Ischemic Score was determined from information 
provided by participants, family members, family physicians and/or medical 
charts; thus, it was completed before testing began.
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Testing Materials
G-LAMB Paragraph (Hublev. 1995 :^ The Paragraph from the G-LAMB is 
administered using an intentional leaming procedure which means that the 
participant is informed of the memory component to the task. The Paragraph is 
read aloud to each subject by the tester, following which the participants have 
30 seconds to read and study the story themselves'*. Subjects are then asked to 
recall all they can remember about the story. There are two acquisition (i.e., 
leaming) trials. After a 10 minute delay inten/al, the subject is again asked to 
recall all he or she can remember about the Paragraph. For each of the leaming 
trials and the delayed intenral trial, the maximum possible free recall (FR) score 
is 21 points. After the free recall portion of the delay trial, subjects are given a 
recognition task in which they are asked four-option multiple choice questions 
about any parts of the Paragraph they could not remember or that they recalled 
incorrectly. The maximum possible score for free recall plus recognition (FR + 
rec) is also 21 points.
G-LAMB Figure fHublev. 19951: As with the Paragraph, the Figure from the 
G-LAMB is administered using an intentional leaming procedure. The Figure is 
presented to each subject for 30 seconds. The Figure is then removed and 
participants are given 2 minutes to draw as much of the Figure as they can from 
memory. There are three acquisition trials. After 10 minutes, a delay trial is 
administered in which subjects are again asked to draw as much of the Figure as 
possible from memory without viewing the Figure first. Finally, a copy trial is
'' If  subjects are unable to read to themselves, the paragraph is read to them again.
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administered in which subjects are asked to copy the Figure while it is in front of 
them. The maximum possible score for any trial is 26 .^
Mini-Mental State Examination (MMSE -  Folstein et al.. 1975 :^ The MMSE is a 
quick screening test of cognitive functioning. It is administered to assess the 
level of cognitive functioning in the AO subjects. The 100-point, modified MMSE 
(3MS) was not selected because recent research has shown that adding 
additional items and modifying the scoring system has not significantly improved 
the test's sensitivity and specificity (Tombaugh, McDowell, Kristjansson & 
Hubley, 1996).
Geriatric Depression Scale fGDS -  Yesavaoe et al..19831: The GDS is a 30- 
item questionnaire designed to screen for depression in the elderly using a 
yes/no format. The scale has been renamed the "Life Satisfaction Scale” in 
order to counteract potential social desirability bias in responses.
The Revised Hachinski Ischemic Scale fiS - Hachinski et al.. 1975: Rosen et al.. 
19801: The revised IS, an 8-item clinical assessment tool, is used to help 
distinguish vascular dementia (VaD) from AD dementia. Although some recent 
research questions the discriminative ability of the IS (Swanwick & Coen, 1995), 
it remains the best option for differentiating VaD from pure examples of AD 
(Tatemichi, Sacktor & Mayeux, 1994; Verhey, Lodder, Rozendaal & Jolies,
1996).
 ^The reader should be aware (hal no cross-cuUural research has been conducted with either of the G-LAMB 
subtests and thus, familiarity or lack of familiarity with the type or content of test materials could have an 
impact on performance.
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Hublev Depression Scale (HDS -  Hublev. 1994k The HDS is a 16-Item 
questionnaire, with a yes/no format, designed to screen for depression in the 
elderly. In the present study, the scale is retitled the “CMAR Life Satisfaction 
Scale” in an attempt to avoid a social desirability bias in responding. The HDS is 
in the development stage and is not validated; thus, it was used as a filler task 
only and was not included in the analyses.
LAMB Word List B fHublev. 1995): This 15-item word list, used to assess verbal 
leaming and memory, is first read aloud to subjects who are next asked to 
verbally recall the words in any order. There are 5 acquisition trials in which both 
free and cued recall are used. There is a 20-minute delayed recall trial followed 
by a recognition trial. Maximum score on any trial is 15.
LAMB Simple Figures (Schmidt & Tombauoh. 1995: Tombauoh & Schmidt.
19921: This test is used to assess visuospatial leaming and memory. A card 
containing four simple designs is presented for 15 seconds. The card is 
removed and the subject is asked to draw all four figures in the same order in 
which they appeared on the card. There are three acquisition trials followed 20 
minutes later by a free recall trial and finally a copy trial. Maximum score on any 
trial is 16.
Boston Naming Test (BNT -  Kaolan. Goodolass. & Weintraub. 19831: The 
Boston Naming Test assesses language deficits (specifically, anomia) by 
requiring subjects to name each of 60 line drawings of objects ranging in 
familiarity from “bed” to "protractor”. If the person is unable to correctly name the 
drawing, a stimulus cue can be given (e.g., for "bed” - it is something you sleep
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on). If the Individual is still unable to name the object, a phonemic cue is given 
(e.g., for “bed” - it starts with the sound of “b”). In the present study, the 30-item 
empirical version of the BNT was used (Williams, Mack & Henderson, 1989).
This short form was empirically derived to maximally discriminate between 
Alzheimer patients and normal controls. The 30-item empirical version has been 
found to correlate 0.97 with the 60-item BNT (Tombaugh & Hubley, 1997).
The Clock Test (Rouleau et al.. 19921: The Clock Test is a two-component 
measure of visuospatial constructional performance with both command and 
copy conditions. In the command condition, the participant is given a blank 
sheet of paper and asked to draw a clock, putting in all the numbers and drawing 
the hands to read 10 after 11. Next, the subject is shown a clock drawing that is 
three inches in diameter, with all numbers in place and the hands set to 10 after
11. The participant is given another piece of paper and asked to copy the model 
while continuing to view it. A quantitative scale (Scale 1) is used to evaluate 
inclusion, and accuracy, of basic clock components in both command and copy 
condkions (Rouleau et. al., 1992). Maximum possible score is 10. A qualitative 
scale (Scale 2) assesses graphomotor errors, hand/number placement, and 
executive control errors in each condition (Libon et al., 1996). One point is given 
for each error committed up to a maximum score of 10.
The Verbal Fluencv Task (FAS and Animals -  Borkowski. Benton & Soreen. 
19671: The Verbal Fluency Task (FAS and Animals) has been shown to be 
sensitive to brain injury and is administered as a measure of language ability. In 
the phonemic component (FAS), participants are Instructed to say as many
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words as possible that begin with a letter of the alphabet, excluding proper 
nouns. The letters F, A, S are presented in that order and, in each case, the 
subject has 60 seconds to list as many words as possible that begin with the 
letter presented. In the semantic component (Animals), participants are given 
60 seconds to name as many animals as possible. In both test components, one 
mark is given for each correct word produced. Scores received for F, A, and 8 
are summed to arrive at the phonemic score. The total number of animals 
correctly named is the semantic score.
Data Analvsis
Data analyses were conducted to compare performance on the G-LAMB 
Paragraph and the Figure between : (1) the entire AD sample and the norms, 
and (2) those with mild AD and those with moderate AD. These analyses looked 
at performance in terms of learning, memory, rates of forgetting, and, in the case 
of the Figure, visuospatial constructional skills. Two-way mixed, repeated 
measures ANOVAs, with one between-group factor (group) and one within-group 
factor (trials), were conducted to evaluate pattems of learning across acquisition 
trials. Independent sample t-tests were used to compare levels of memory 
performance on delay trials. Difference scores (i.e., the difference between the 
last acquisition trial and the free recall delay trial) and savings scores (i.e. the 
percent of information retained from the last acquisition trial to the free recall 
delay trial) were calculated and appropriate t-tests performed in order to assess 
rates of forgetting. Visuospatial construction was examined by conducting 
Independent sample t-tests on the Figure copy trial scores.
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In addition, an examination of the level and range of scores obtained by 
AD participants on both the verbal and visuospatial subtests of the G-LAMB was 
carried out to determine if floor effects, often exhibited by persons with AD on 
memory tests, had been avoided. Results are reported primarily in terms of 
descriptive statistics (e.g., mean, standard deviation, minimum and maximum) 
and through the use of graphs.
The reiationships between the G-LAMB Paragraph and other verbal tests 
(e.g., LAMB Word List B and the Verbal Fluency Tasks) were examined by 
computing Pearson product moment correlations. In the same vein, correiations 
were used to assess the relationship between the G-LAMB Figure and other 
visuospatial tests (e.g., LAMB Simple Figures and the Clock Test) and to 
compare AD group performance on the Paragraph to performance on the Figure. 
Finaily, demographic infonnation (i.e., age, education, and MMSE score) of the 
AD group was correlated with performance on the G-LAMB subtests.
Throughout the results section, partial eta-squared (eta-sq) is noted for 
each significance test as a measure of effect size. Effect size provides a means 
of describing the size or magnitude of an effect that is less dependent on sample 
size than the p-value (Kirk, 1996; Zumbo & Hubiey, 1998). The presence of 
substantial effect sizes can assist in the verification of real effects even in smail 
sampies. Thus, with the relatively small sample in the current study, the 
reporting of effect size is of particular importance. The criteria for evaluating
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partial eta-sq is presented by Kirk^  (1996) as follows: a small effect is .010 to 
.058, a medium effect is .059 to .137 and a large effect is greater than .137. 
Complete results of the data analyses are presented in the next chapter.
" Although Kirk presents these criteria to evaluate omega squared, according to Zumbo (personal 
communication, June 1998), partial eta squared provides a similar measure of strength of association as 




Comparison of Total AD Group to Normative Sample
It may seem a foregone conclusion tfiat there will be differences in 
performance between the clinical (i.e., AO) and normative samples on both the 
verbal and visuospatial G-LAMB subtests, particularly given the ceiling effects in 
scores attained by healthy older adults in the normative study (Hubiey, 1995) 
and the well-documented memory deficits integral to AD. However, It is 
necessary to examine this relationship and confirm these expectations before 
proceeding with the analysis of the clinical sample that is the primary focus of the 
current research.
1) G-LAMB Paragraph IVerbah
Figure 4 presents the trial by trial performance on the G-LAMB Paragraph 
for the Total AD group and for the normative sample. Learning was examined 
using a 2 x 2 Group (AD or Norms) x Trials repeated measures ANOVA. The 
Group X Trials interaction was not significant, F(1,181) = 1.01, n.s., partial eta-sq 
= .006, meaning that the effect of one factor (i.e., group) is not dependent on the 
other factor (i.e., trials) or vice versa. A significant within-subjects main effect for 
Trials was found, F(1,181) = 102.99, p = .000, partial eta-sq = .363. In other 
words, there was a statistically significant difference (increase) in performance 
between Trial 1 and Trial 2 for both the normative sample and the Total AD 
group. A significant between-groups main effect was also identified, F(1,181) = 














Delay (fr+rec)Delay (fr)1 2
Trials
Figure 4. Mean performance on G-LAMB Paragraph Trials for Norms (n=169)
and Total AD group (n=14).
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than the performance of the AD group on both trials (Trial 1 : Norm: M = 16.6,
SD = 3.07; AD: M = 8.6, §D = 6.73; Trial 2: Norm: M = 19.3, §D = 2.13; AD: M =
10.7, §D = 7.31).
Memory for the Paragraph was examined by conducting Independent 
sample t-tests on the free recall (FR) and free recall plus recognition (FR + rec) 
trial scores that were obtained following a 10-mlnute post-acqulsltlon delay 
Interval. In the FR condition, the mean performance of the Total AD group (M = 
9.1, §D = 8.05) was significantly lower than that of the norms (M = 18.1, SD = 
2.71), t(181) = 9.53, p = .000, partial eta-sq = .334. Investigation of the FR + rec 
condition also revealed a significant difference In performance between the Total 
AD group (M = 15.7, §D = 5.96) and the normative sample (M = 20.6, §D = 
0.70), t(181) = 9.93, p = .000, partial eta-sq = .352.
Rate of forgetting was examined using two methods: (a) difference 
scores and (b) savings scores (I.e., percent retained). When difference scores 
were employed. Independent sample t-tests Indicated that there was no 
statistically significant difference In forgetting between the norms (M = 1.2, SD =
1.79) and the Total AD group (M = 1.6, SB = 2.14), t(181) = 0.71, n.s., partial 
eta-sq = .003. Use of savings scores, however, revealed a significant difference 
In the percent of Infonnation retained for the norms (M = 93.7%, SD = 10.3%) 
versus the Total AD group (M = 67.5%, SB = 48.0%), t(180) = 5.75, p = .000, 
partial eta-sq = .155 .^
In support of the hypotheses presented, performance of the normative
 ^One moderate AD participant was excluded from the savings score analysis as this individual had a score 
of zero on both the final acquisition and delay trials of the Paragraph; thus, df =  180.
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sample on Paragraph learning and memory tasks was consistently and 
significantly higher than that of the Total AD group. The one exception was the 
lack of a significant difference between norm and AD group performance when 
rate of forgetting was examined using the difference score method.
2) G-LAMB Figure (Visuosoatiah
Trial by trial performance on the G-LAMB Figure for the Total AD group 
and the normative sample is presented in Figure 5. Visuospatial construction is 
always examined to determine whether deficits in leaming and memory are the 
result of visuospatial constructional difficulties (such as hemineglect). This did 
not appear to be the case for any of the study participants. Using an 
independent samples t-test to examine mean differences between the normative 
sample and the Total AD group on the Figure copy trial, results indicate that the 
performance by the Total AD group (M = 23.4, = 3.25) was significantly lower
than that of the normative sample (M = 25.9, §D = 0.44), t(13.04) = 2.88, p = 
.013, partial eta-sq = .388 .^ However, both groups performed at a high level 
given the maximum possible score of 26 on the copy trial.
A 2 X 3 Group (AD or Norms) x  Trials repeated measures ANOVA was 
used to investigate leaming. The Group x Trials interaction was not significant, 
F(2,362) = 0.72, n.s., partial eta-sq = .004. However, there was a significant 
within-subjects main effect for Trials, F(2,362) = 87.21, p = .000, partial eta-sq = 
325 and a significant between-subjects main effect for Group, F(1,181) = 
146.84, p = .000, partial eta-sq = .448. Posthoc paired sample t-tests were
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| ig u £ ^  Mean performance on G-LAMB Figure Trials for Norms (n=169) and
Total AD group (n=14).
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conducted to further investigate the rate of leaming from one trial to another. A 
Bonferroni correction (alpha = .025) was used to control for the Type 1 error rate 
(Tabachnick & Fidell, 1996). Results indicate that a significant amount of 
information was acquired from Trial 1 to Trial 2, t(183) = 17.83, p = .000 as well 
as from Trial 2 to Trial 3, t(183) = 9.3, p = .000 .^ Thus, regardless of group 
membership, there was a statistically significant increase in leaming from both 
Trial 1 to 2 and Trial 2 to 3, even though scores of the normative sample were 
consistently higher than those of the Total AD group (see Table 3).
Table 3
Means and Standard Deviations for G-LAMB Figure Leamino Trials (Norms vs 
Total AD Grouol
Trials
Norms (n = 169) Total AD (n = 14)
Mean Std Deviation Mean Std Deviation
Trial 1 18.1 4.52 6.1 5.68
Trial 2 22.3 4.01 9.4 6.97
Trial 3 24.0 2.80 11.2 7.36
Evaluation of memory performance on the Figure was conducted using an 
independent sample t-test to compare the 10-minute delay trial scores for
 ^Effect sizes for the posthoc paired sample t-tests are not provided as there is no widely accepted measure 
recognized at this time (Zumbo, personal communication, June 1998).
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each group. Results show that the mean performance of the Total AD group (M 
= 9.7, SD = 8.9) was significantly lower than that of the normative sample (M =
23.8, SD = 3.1), t(181) = 13.31, p = .000, partial eta-sq = .495.
Rate of forgetting was assessed using both difference scores and savings 
scores. The independent sample t-test of difference scores for the Total AD 
group (M = 1.6, SD = 2.83) and the normative sample (M = 0.2, SD = 1.47) was 
statistically significant, t(181) = 3.11, p = .002, partial eta-sq = .515, suggesting 
that those with AD had a higher rate of forgetting than those without the disease. 
Savings scores revealed a similar significant result, t(13.07) = 2.77, p = .016, 
partial eta-sq = .484’®, with the Total AD group (M = 65.6%, gD = 45.6%) 
retaining a smaller percentage of learned information than the normative sample 
(M = 99.3%, §D = 8.25%) after a brief delay.
Thus, as proposed in the hypotheses, the normative sample performed 
significantly better than the AD participants on all G-LAMB Figure leaming, 
memory and visuospatial constructional trials.
Comparison of Mild and Moderate AD Groups
With the overall context provided by the initial comparisons between the 
Total AD group and the normative sample, attention can now be directed toward 
evaluation of the performance of the clinical sample. The current study was 
designed precisely to determine the potential utility of the G-LAMB for assessing 
and tracking leaming and memory performance in people with AD as well as 
differentiating the performance level of those individuals with mild or moderate
Due to a difference in group variances > S;l (Howell, 1995), the unequal variance t-value and df were 
used.
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stages of AO. As such, the analyses of primary interest are those involving the 
performance of the Mild and Moderate AD groups.
1) G-LAMB ParaGraph (Verbah
Figure 6 provides the trial by trial performance of the Mild and Moderate 
AD groups on the G-LAMB Paragraph. With this visual display providing an 
initial glimpse at the range of scores and level of performance for the clinical 
sample, a more in-depth evaluation of leaming, memory, rates of forgetting and 
the relationship of the Paragraph subtest to other verbal tests, was undertaken.
A 2 X 2 Group (Mild or Moderate AD) x Trials repeated measures ANOVA 
was conducted to examine leaming performance between participants with mild 
versus moderate AD on the Paragraph. The Groups x Trials interaction was not 
significant, F(1,12) = 1.59, n.s., partial eta-sq = .117"; thus, any significant main 
effect for Group and/or Trials is independent of the other factor. In fact, analysis 
did reveal a significant within-subjects main effect for Trial, F(1,12) = 7.93, p = 
.016, partial eta-sq = .398 as well as a significant between-groups main effect for 
Group, F(1,12) = 94.52, p = .000, partial eta-sq = .887. In other words, there is a 
significant change (increase) in scores from Trial 1 to Trial 2 for both groups (i.e., 
leaming is taking place) but the Mild AD group (Trial 1 : M s 14.3, SD = 4.20; Trial 
2: M = 17.4, SD = 2.30) performs consistently higher than the Moderate group 
(Trial 1:M = 2.7, SB = 1.57; Trial 2:M = 4.0, SB = 2.31).
Independent sample t-tests on the Paragraph FR and FR+rec delay trials 
were conducted to assess memory performance. Examination of the mean
















Figure 6. Mean performance on G-LAMB Paragraph Trials: Mild (n=7) and
Moderate (n=7) AD groups.
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differences between the Mild AD group (M = 16.6, SD = 1.72) and the Moderate 
AD group (M = 1.7, SD = 2.93) on free recall revealed that the Mild group 
achieved a significantly higher recall score than the Moderate group, t(12) =
11.58, p = .000, partial eta-sq = .918. Inspection of the FR + rec trials also 
revealed a statistically significant difference between the Mild (M = 20.3, gD = 
0.76) and Moderate (M = 11.4,gD = 5.53) AD groups, t(12) = 4.20, p = .001, 
partial eta-sq = .595.
Rate of forgetting was examined using both difference scores and savings 
scores. The difference score method uncovered no significant differences 
between the Mild (M = 0.9, gD = 1.68) and Moderate (M = 2.3, §D = 2.43) AD 
groups, t(12) = 1.28, n.s., partial eta-sq = .120^ .^ Savings scores provide a 
different view with the Mild AD group (M = 95.9%, SD = 10.5%) retaining 
significantly more of the leamed information than the Moderate AD group (M = 
34.3%, SD = 54.2%), t(11) = 2.96, p = .013, partial eta-sq = .444’^
As predicted in the study hypotheses, the Mild AO group performed at a 
consistently and significantly higher level than the Moderate AD group on the 
leaming and memory components of the Paragraph subtest. The only exception 
was the rate of forgetting when examined by the difference score method where 
there was no statistically significant difference between the Mild and Moderate 
AO group performance.
'* Given the medium effect size, it is possible that a larger sample size may have produced a statistically 
significant result.
One moderate AD participant was excluded from the savings score analysis as this individual had a score 
of zero on both the final acquisition and delay trials of the Paragraph; thus, d f = l l .
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Relationship of G-LAMB Paragraph Performance to Other Variables
The strength of the relationships between age. education, and MMSE 
score and performance on the G-LAMB Paragraph by individuals with AD was 
examined using Pearson product moment correlations. These results are shown 
in Table 4.
Table 4
Correlation of Aoe. MMSE Score and Education to G-LAMB Paragraph 
Performance for Total AD Group fn = 14^
Trial Age MMSE Education
1 -.66" .86" .48
2 -.69" .87** .41
FR -.65* .89** .40
FR + rec -.63* .67** .14
Note. MMSE = Mini-Mental State Examination; FR = free recall delay trial; rec = 
recognition delay trial.
*p< .05 .  **p<.01.
Correlations between age and Paragraph trial scores were all significant 
and ranged from -.63 to -.69 (all p < .05). Thus, as age increased. Paragraph 
trial scores tended to decrease. Likewise, the correlations between the 
Paragraph trial scores and MMSE scores were all significant and ranged from 
.67 to .89 (all p < .01). Therefore, the higher the MMSE score, the higher the 
Paragraph leaming and memory performance. Finally, the correlations between 
education level and performance on the Paragraph trials ranged from .14 to .48
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but were not statistically significant.
Pearson product moment correlations were also calculated to assess the 
strength of the relationship between the G-LAMB Paragraph and other verbal 
tests administered to the Total AD group in the study (see Table 5).
Table 5




WL1 W L5 WL (FR) WL (rec) BNT FAS Animals
1 .81** .85** .92** .72** .82** .55* .79**
2 .74** .89** .91** .79** .81** .42 .87**
FR .76** .88** .96** .89** .81** .47 .74**
FR+rec .66** .75** .82** .86** .73** .34 .65*
Note. Para = G-LAMB Paragraph; WL = Word List B, 1 = Trial 1,5 = Trial 5 
(last acquisition trial), FR = free recall delay trial, rec = recognition delay trial; 
BNT = Boston Naming Test.
*p<.05. **p<.01.
Correlations between the G-LAMB Paragraph trials and the LAMB Word 
List B trials were all significant and ranged from .66 to .96 (all p< .05). The 
relationships between the Paragraph trials and the empirical version of the 
Boston Naming Test were also significant and ranged from .73 to .82 (all p < 
.01). Similarly, correlations between the Paragraph trials and semantic verbal 
fluency (Animals) were significant and ranged from .65 to .87 (all p < .05). The 
relationship between phonemic verbal fluency (FAS) and the G-LAMB
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Paragraph, however, was significant only when comparing Trial 1 of the 
Paragraph to FAS, r = .55, p = .041. Correlations between FAS and the other 
G-LAMB Paragraph trials ranged from .34 to .47 but were not statistically 
significant.
As predicted in study hypotheses, performance of the AD sample on the 
G-LAMB Paragraph subtest was significantly correlated with their performance 
on other verbal tests. The only exception was the relationship between 
Paragraph performance and performance on the phonemic component (FAS) of 
the Verbal Fluency Test in which there was no significant correlation.
2) G-LAMB Figure fVisuosoatiah
Trial by trial performance by the Mild and Moderate AD groups on the 
G-LAMB Figure is presented in Figure 7. With this visual display of the data in 
mind, further analyses were conducted to investigate visuospatial construction, 
leaming, memory, rates of forgetting and the relationship between the 
performance of AD participants on the Figure subtest and their performance on 
other visuospatial tests.
Visuospatial constructional abilities were examined in order to identify any 
deficits and to report the mean level of performance for each AD group. Results 
of an independent sample t-test indicate no statistically significant difference 
between the copy trial scores of the Mild AD group (M = 24.2, §D = 1.13) and the 
Moderate AD group (M= 22.3, §D = 4.35), t(12) = 1.26. n.s., partial eta-sq 
=.117^\ Given the maximum possible score of 26, both groups performed at a





















Figure 7. Mean performance on G-LAMB Figure Trials: Mild (n=7) and Moderate 
(n=7) AD groups.
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high enough level that visuospatial constructional deficits should not confound 
the results of leaming and memory analyses that follow.
To investigate leaming, a 2 x 3 Group (Mild vs Moderate AD) x Trials 
repeated measures ANOVA was conducted. The Group x Trials interaction was 
significant, F(2,24) = 14.23, p = .000, partial eta-sq = .542; thus, a significant 
effect on one factor (e.g.. Group) is conditional upon the other factor (e.g., trials). 
Posthocs were conducted to determine the precise nature of the interaction. 
Using a Bonferroni correction (Tabachnick & Fidell, 1996) to control for the Type 
1 error rate (alpha = .0125), four paired sample t-tests were performed to 
investigate the rate of leaming occurring from one trial to another for each group. 
Findings indicate that the only statistically significant increase in the amount 
leamed was by the Mild AD group between Trial 1 (M = 9.1,§D = 6.25) and 
Trial 2 (M = 14.7, §D = 4.93), t(6) = 4.65, p = .004’®. P-values for all other 
comparisons were greater than .0125 (see Table 6 for complete posthoc results). 
A significant between-subjects main effect was found for Group, F(1,12) = 16.87, 
p = .001, partial eta-sq = .584 and a significant within-subjects effect was found 
for Trials, F(2,24) = 36.07, p = .000, partial eta-sq = .750. Neither main effect 
contradicts the interaction findings; thus, both main effects are interpretable. 
Therefore, ignoring group status, some leaming does occur from one trial to the 
next but the scores obtained by the Mild AD group are consistently higher (see 
Table 7 for Mild and Moderate AD group trial means).
Memory performance on the G-LAMB Figure was examined using an
Effect sizes for the posthoc paired-sample t-tests are not provided as there is no widely accepted measure 
recognized at this time (Zumbo, personal communication. June 1998).
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Table 6
Posthoc Paired t-tests for G-LAMB Figure Learning Trials
Mild AD (n = 7) Moderate AD (n = 7)
Trial t-value df p-value t-value df p-value
1 to 2 4.65 6 .004 3.03 6 .023
2 to 3 2.84 6 .029 1.83 6 .117
Note. Significant p-value is < 
rate.
.0125 due to Bonferroni correction for Type 1 error
Table 7
Means and Standard Deviations for G-LAMB Ficure Leaming Trials
Mild AD (n = 7) Moderate AD (n = 7)
Trials Mean Std Deviation Mean Std Deviation
1 9.1 6.25 3.2 3.30
2 14.7 4.93 4.1 3.87
3 17.2 4.94 5.3 3.00
Independent sampies t-test to compare the 10-minute delay trial scores for each 
group. Results indicate that the mean memory performance of the Mild AD 
group (M = 17.3, §D = 5.41) was significantly higher than for the Moderate AD 
group (M = 2.1, SD = 2.61 ), t(12) = 6.71, p = .000, partial eta-sq = .789.
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Both the difference score and the savings score methods were used to 
assess rates of forgetting between the final leaming trial and the 10-mlnute 
delay. The Independent sample t-test of difference scores for the Mild AD group 
(M = -0.1 ,§D  = 1.81) and the Moderate AD group (M = 3.1,gD = 2.88) was 
statistically significant, t(12) = 2.50, p = .028, partial eta-sq = .342, suggesting 
that rate of forgetting on the G-LAMB Figure Increases with the severity of the 
disease. A similar result Is Indicated by the savings score technique. The Mild 
AD group (M = 99.7%, SD = 12.2%) retained a larger percentage of Information 
leamed than did the Moderate AD group (M = 32.9%, gD = 43.4%), t(12) = 3.93, 
p = .002, partial eta-sq = .562.
Relationship of G-LAMB Figure Performance to Other Variables
Pearson product moment correlations were used to examine the strength 
of the relationships between age, education and MMSE score and performance 
on the G-LAMB Figure In the Total AD group. Correlations between age and 
Figure trial scores were all significant, ranging from -.69 to -.84 (p < .01) except 
for the copy trial which was not statistically significant, r = -.29. Thus, for leaming 
and memory trials, the greater the age the lower the score; however, for the copy 
trial (assessing visuospatial constructional abilities), age was not related to level 
of perfonnance. A similar pattem was found when comparing the Figure trial 
scores to MMSE scores. All correlations were significant, ranging from .69 to .88 
(all p <.01 ) except for the copy trial which was not significant, r = .25.
Examination of the relationship between education level and Figure trial success 
revealed mixed results. Correlations were statistically significant for Trial 3
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(r = .59, p = .028) and for the copy trial (r = .71,p = .005). The remaining Figure 
trials correlated with years of education but were not statistically significant. 
Education correlated .53 (p = .053) with performance on the delay trial which, 
although not statistically significant, did show a trend and suggests that a larger 
sample size might have produced a significant result (see Table 8 for complete 
results).
Table 8
Correlation of Aoe. MMSE Score, and Education to G-LAMB Figure 
Performance for Total AD Group fn = 14t
Trial Age MMSE Education
1 -.77** .69** .48
2 -.77** .84** .48
3 -.84** .88** .59*
Delay -.69** .88** .53
Copy -.29 .25 .71**
Note. MMSE = Mini-Mental State Examination.
" p <.05. **p<.01.
In order to evaluate the strength of the relationship between the G-LAMB 
Simple Figure and other visuospatial tests given to the Total AD group during the 
course of the study, Pearson product moment correlations were computed (see 
Table 9). Correlations between the G-LAMB Figure leaming and memory trials 
and the LAMB Simple Figure leaming and memory trials were all significant and 
ranged from .66 to .85 (all p < .05). The relationship between the G-LAMB
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Figure and LAMB Simple Figures copy trials was not statistically significant, 





















1 .69" .73** .80** .06 .29 -.02 .35 -.47
3 .66* .73** .85** -.15 .53 -.26 .12 -.36
delay 66* .66* .84** -.09 .52 -.30 .16 -.36
copy -.03 .27 .20 .39 .61* -.64* .10 -.63*
Note. LSF = LAMB Simple Figure: 1 = Trial 1; 3 = Trial 3 (last aquisition trial); 
cm 1 = command, scale 1 ; cm 2 = command, scale 2; copy 1 = copy, scale 1 ; 
copy 2 = copy, scale 2.
*p<.05. **p<.01.
Correlations between the G-LAMB Figure leaming and memory trials and 
freehand drawing of a clock (command condition) ranged from .29 to .53 and 
were not statistically significant (all p > .05) when Scale 1 (quantitative score) 
was used to score performance. It should be noted, however, that Figure Trial 3 
and the delay trial produced trends (p< .06) that with a larger sample size, might 
have resulted in significant findings. When Scale 2 (qualitative error score^ )^ 
was used, none of the correlations with the Figure leaming and memory trials 
was statistically significant (r = -.02 to -.30, all p > .05). However, correlations
The greater the number of errors made, the higher the score.
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between the Figure copy trial and the Clock Test command condition using both 
Scale 1 (r = .61, p< .05) and Scale 2 (r = -.64, p <.05) were statistically 
significant. Thus, if a participant produces a high quality freehand clock 
drawing, the same individual will tend to also perfomi well on the G-LAMB Figure 
copy trial.
Correlations between G-LAMB Figure leaming and memory trials and 
performance when copying the picture of a clock ranged from .12 to .35 and 
were not statistically significant when Scale 1 (quantitative score) was used to 
score performance. There were also no statistically significant correlations when 
Scale 2 (qualitative error score) was used (r = -.36 to -.47, all p > .05). The 
correlation between the Clock Test copy condition and the G-LAMB Figure copy 
trial was not significant when Scale 1 was used to evaluate performance (r & .10, 
p > .05) but was statistically significant when Scale 2 was used (r = -.63, p < .05).
Consistent with the study hypotheses, the performance by AD participants 
on the leaming and memory components of the G-LAMB Figure was significantly 
correlated with leaming and memory performance on the LAMB Simple Figures. 
However, there was no significant correlation between copy trials as was 
expected. Correlations between the G-LAMB Figure and the Clock Test 
generally did not support the prediction of a significant relationship between 
similar tests. The only statistically significant finding that was predicted was the 
relationship between the Clock Test copy trial (scored using Scale 2) and the G- 
LAMB copy trial.
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Relationships Between G-LAMB Paragraph and Figure Subtests
Examination of the relationships between the leaming and memory 
components of the two G-LAMB subtests reveal correlations that are all 
statistically significant and range from .61 to .91 (all p < .05). However, none of 
the correlations (ranging from .10 to .26, all p > .05).between the Paragraph trials 
(assessing leaming and memory) and the Figure copy trial (assessing 
visuospatial constructional abilities) are significant. Complete results can be 
found in Table 10.
Table 10
Correlation Between G-LAMB Paragraph and Figure Subtests For Total AD 
Group In = 141
Paragraph
Figure 1 2 FR FR + rec
1 .71** .61* .66** .62*
2 .86** .85** .88** .80**
3 .87** .87** .89** .76**
delay .90** .90** .91** .72**
copy .23 .23 .22 .10
Note. FR = free recall delay trial; rec = recognition delay trial.
*p<.05 .  **p<.01.
Thus, with few exceptions, the research hypotheses were met. A




The main objective of this study was to determine the usefulness of the 
G-LAMB for monitoring leaming and memory performance in individuals already 
diagnosed with AD and for differentiating among different levels of severity of 
AD. Overall, the results obtained appear to confirm the G-LAMB's utility for 
those with Mild to Moderate level AD.
Historically, leaming and memory test scores obtained by persons with AD 
have been so low that it was difficult to either distinguish one level of AD from 
another or to track changes in performance over time. Such shortcomings pose 
serious difficulties when it comes to prescribing and evaluating treatment 
regimes. These days, with the incidence of AD increasing year by year and new 
pharmacological and other treatments on the horizon, developing a instrument 
which can differentiate levels of AD and allow for a high enough score to avoid 
floor effects has become critical. For example, physicians are now prescribing 
Aricept, a new pharmacological treatment designed to deal with symptoms 
associated with early AD such as memory loss and difficulties with leaming. An 
objective measure is needed in order to determine whether an individual is an 
appropriate candidate for the drug (i.e., should be at a mild stage of the disease) 
and to evaluate the impact of the treatment (Feldman, 1998). The G-LAMB 
appears to be such an instrument with regard to the assessment and monitoring 
of verbal and visuospatial leaming and memory in people already diagnosed with 
AD.
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As predicted in the study hypotheses, the normative sample performed at 
a consistently higher level on both the G-LAMB Paragraph and Figure than 
participants with AD. More specifically, the normative sample showed 
significantly better performance than individuals with AD in learning, memory, 
rate of forgetting and visuospatial construction. Although these findings may 
seem self-evident, when a new test (such as the G-LAMB) is being evaluated 
with a clinical sample for the first time, it is necessary to confirm the expected 
relationship between the clinical sample and the normative data. In addition, 
consistent with the research hypotheses, test scores were high enough in the 
Mild AD group to allow for monitoring changes in performance over time. The 
G-LAMB is a tracking, rather than a diagnostic, test battery. Therefore, high 
scores by the Mild AD group are very desirable (even if they are not 
distinguishable from normative perfonnance) because they allow for longer 
periods of monitoring than would be afforded by lower scores.
G-LAMB Paragraph Performance
Analysis of the Total AD sample revealed a differentiation between the 
scores of the Mild and Moderate AD groups on both G-LAMB subtests. The 
G-LAMB Paragraph appears to provide some needed and previously less 
accessible information about those with Mild and Moderate levels of AD. First, 
there is a clear differentiation in the performance level of the Mild and Moderate 
AD groups for both leaming and memory test components. If one looks at the 
performance of individuals in these two groups only, there is virtually no overlap 
of scores between the two groups (see Figure 8). This is, in part, due to the
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Figure 8. Individual performance on G-LAMB Paragraph Trials for AD groups: 
Mild (n=7), Moderate (n=7).
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avoidance of floor effects in the Mild AD group. For example, with Mild AD 
scores ranging from 13 to 20 (out of a possible 21) following the last acquisition 
trial, there is ample room to monitor changes in leaming performance over time. 
Ability to track changes beyond the Moderate AD level is limited by the (low) 
level of their acquisition test scores (ranging from 0 to 7). Some moderate 
individuals could be tracked for limited periods of time but most have scored too 
low to allow for any effective future monitoring. Even with this limitation in the 
Moderate group, scores on the G-LAMB Paragraph differentiate the Mild from 
the Moderate group and provide valuable information about the current level of 
leaming and memory performance in both groups.
Although the Mild AD participants produced higher memory scores than 
the Moderate group on both the FR and FR+rec trials, it is interesting to note the 
relatively high level of performance of the Moderate AD group in the FR+rec 
condition. Mild AD scores ranged from 19 to 21 whereas the scores of those 
with Moderate level AD ranged from 7 to 21. Normative performance for FR+rec 
ranges from 17 to 21, strikingly similar to the range of Mild AD scores. Clearly, 
the opportunity to choose the correct answer from amongst other answers is a 
considerably easier task than searching for the answer in memory with no cue 
whatsoever. Even though the Moderate AD group performance is significantly 
lower than Mild Group performance on the FR+rec trial, the relatively higher 
scores in both AD groups suggests that, consistent with the literature, recognition 




The G-LAMB Figure Is an Improvement over many previously available 
tests (such as the Rey-Osterrleth Complex Figure Test) In terms of providing 
differentiation between performance of Mild and Moderate AD groups and 
avoiding floor effects In the Mild group. However, the G-LAMB Figure appears 
somewhat less successful at both of these tasks than the G-LAMB Paragraph. 
For example, when examining Individual performance for each group (see Figure 
9), there Is not as clear a differentlon between groups In the sense that the 
performance of the two groups Is not as distinct and there Is some overlap 
between the groups. Specifically, the leaming scores for the Mild AD group 
range from 3 to 22 on Trial 1 and 11.5 to 26 on Trial 3 whereas the Moderate AD 
group scores range from 0 to 10 on Trial 1 and 1 to 10 on Trial 3. There Is one 
Moderate AD Individual who crosses over Into Mild "territory". But even 
removing this Moderate participant from the picture (whose performance could 
potentially be explained by a high premorbid level of visuospatial ability) does not 
alter the fact that the clear group distinction found in the Paragraph trials is not 
found in the Figure trials. The other limitation of the Figure findings Is that 
although floor effects are avoided, the overall leaming and memory performance 
level Is lower than was anticipated. Consider an individual with Mild AD who 
scores 10 out of a possible 26 on the Figure memory trial. Although 
performance could be monitored until it decreased to zero, it would be for a more 








Figure 9. Individual performance on G-LAMB Figure Trials for AD groups: Mild 
(n=7), Moderate (n=7).
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In this context, It is interesting to note that the only statistically significant 
increase in the amount learned from one Figure trial to another was by the Mild 
AD group from Trial 1 to Trial 2. This means that the leaming cunre for the 
Moderate AD group was essentially flat whereas for the Mild group, the cun/e 
leveled off after the second leaming trial. In other words, participants are not 
fully utilizing the three leaming trials available to them. They have stopped 
leaming. Thus, in order to increase Figure performance levels enough to clearly 
differentiate the Mild and Moderate AD groups and allow for tracking changes 
over a substantial period of time, adding extra leaming trials will not help. An 
easier form of the Figure may be needed.
Putting all this information together, it appears that the G-LAMB Figure, 
although a step in the right direction, may still be too difficult for optimum use 
with an Alzheimer population. It would seem that development of a less difficult 
revised version of the Figure might be the next logical step in order to reach the 
high level of utility achieved with the Paragraph subtest.
It is interesting to note that the visuospatial constructional performance of 
the Mild and Moderate AD groups on the Figure copy trials did not differ. This 
finding does not support study hypotheses but is consistent with the literature in 
the sense that memory deficits and not difficulties in constructional abilities are 
usually the among the first signs of AD. What the current findings do appear to 
suggest is that constructional abilities can remain relatively intact even into the 
moderate stages of Alzheimer’s Disease.
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Conclusions Regarding Use of the G-LAMB in an Alzheimer Population
The experience of administering the G-LAMB coupled with the study 
findings provide strong support for its use among individuals with Mild to 
Moderate AD. At first glance, restricting test use to mild and moderate disease 
levels may seem to be a weakness in the applicability of the G-LAMB. However, 
the inability to test more severely impaired individuals is consistent with the 
literature. Memory may deteriorate to the point at which the person cannot 
remember the instructions long enough to initiate or complete a task. This is not 
just a matter of sensitivity of leaming and memory tests. In addition, once 
individuals reach a moderate-severe level of AD, other symptoms become more 
prominent (and these require more attention) and may negatively affect the 
assessment process (e.g., language deficits, distractability and lack of 
motivation).
The most immediately apparent improvement over other memory tests is 
the simplicity and brevity of the G-LAMB. These features tackle two basic 
problems encountered when testing individuals with AD: participant frustration 
and floor effects. Because the G-LAMB is a relatively less difficult test, 
performance reaches a higher level than on most traditional tests. As a result, 
the frustration that often accompanies poor performance has been alleviated and 
scores achieved are high enough to allow for tracking changes over time. This is 
important because treatment regimes merely become "a shot in the dark” when 
the impact of the treatment cannot be measured due to a lack of sensitivity in our 
tests to identify performance changes in cognitively impaired groups.
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Another advantage of the G-LAMB is that It Includes two subtests that 
allow assessment of both verbal and visuospatial leaming and memory. This 
addresses a recently acknowledged need In the literature for tests that can 
examine specific memory systems (Mohr, Feldman & Gauthier, 1995). An 
example of the Importance of having these two Independent measures can be 
seen by examining the performance of a study participant with Moderate/Severe 
AD who Is still living Independently In the community. While her scores on the 
Paragraph were actually higher than the scores of all the Moderate participants, 
her performance on the Figure was essentially zero. Having this Information In 
hand, the woman and her family could be advised that moving her to a smaller 
house or to an apartment (which might seem logical given the AD diagnosis) 
would probably be an error as her ability to learn and remember the layout of a 
new place Is severely diminished. This particular woman noted during testing 
that she still likes to go on long walks around the neighbourhood. Test results 
would suggest that she should stick with her current route rather than Introducing 
new ones because getting lost Is a real possibility. At the same time, focusing on 
this woman's unusually well-preserved verbal skills would Increase her ability to 
function and sustain her self-esteem.
The G-LAMB also provides the clinician with Infomnatlon about a person's 
abilities In both leaming and memory. For example, when completing the Figure 
subtest, one study participant scored 10 out of 26 on the last leaming trial but 
dropped to 1.5 out of 26 after the 10 minute delay. Such performance suggests 
that the Individual Is still able to acquire some new visuospatial Information but
G-LAMB Performance 73
cannot retain It for very long. Therefore, it will not be helpful to walk her from 
her room in the care facility to the dining room as a reminder of how to get to 
supper two hours later. The information will be lost long before it is time to eat. 
On the other hand, another study participant scored 9 out of a possible 21 on the 
first leaming trial of the Paragraph, increased his score to 18 at the second trial 
and scored 15 at the free recall delay. With a relatively good capacity for 
leaming and retaining verbal information, it should be helpful to give this man 
verbal reminders about how to get to the dining room or to wash his hands 
before leaving the bathroom. However, someone whose delay score is very low 
would not remember such reminders and might be better served by recently 
designed, computer-controlled "smart" rooms that provide step by step verbal 
instructions to the user (e.g., a "smarf bathroom would tell the user to wash their 
hands and tum out the light before leaving the room).
Another helpful distinction provided by the G-LAMB is the examination of 
an individuai’s performance on a free recall memory task (i.e., no assistance or 
cues are given in recovering the memory) and recognition memory (i.e., the item 
simply has to be recognized and so considerable support is provided). Having 
this information allows the clinician to assess whether providing maximum 
support for remembering will allow the person to, in fact, remember. For 
example, one study participant scored zero out of 21 when trying to free recaii 
information about the Paragraph after a 10-minute delay but scored 10 on the 
free recall plus recognition trial. Clearly, not all of the information is "forgotten”. 
Instead, this individual, despite "bottoming out" on the FR trial, still has some
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ability to remember if assistance is provided. If asked to describe her weekend 
with her family, she might not be able to recall any activities. However, if other 
family members started to describe events, she may very well be able to add 
new information.
Finally, another strength of the G-LAMB is the 10-minute delay interval 
(many tests have 20-40 minute delays) between the last leaming trial and the 
recall trial. In addition to contributing to the brevity of the test, this delay interval 
also reflects the fact that, as the disease progresses, persons with AD are known 
to have a more rapid rate of forgetting than is the case for many other 
dementias. That is, most newly-acquired information is lost from memory within 
the first 10 minutes following acquisition. Thus, the shorter delay interval in the 
G-LAMB provides the clinician with a better means of delineating how early in 
the disease process an individual is showing this rapid forgetting as well as 
assisting the clinician in distinguishing individuals with AD from other types of 
dementia.
Other Findings of Interest
The current research reveals seemingly inconsistent findings regarding 
rates of forgetting. When difference scores, which look at the difference 
between the score at the last leaming trial and the score on the FR delay trial, 
were employed. Mild and Moderate AD groups forgot the same (raw) amount of 
information. However, when savings scores were employed, the percentage of 
information retained from the last acquisition to the delay was significantly higher 
in the Mild group. That is, relative to the amount they had ieamed, the Mild AD
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group forgot less. To clarify the potential source of this apparent difference, 
consider the following example. If an individual with a moderate level of AD 
scores 5 on the last acquisition trial and remembers one item at recall, they have 
the same difference score as an individual with a mild level of AD who scores 15 
on the last acquisition trial and recalls 11 items at delay. Both have forgotten 
four items. Yet, in terms of percent of information retained, the moderate 
individual has retained only 20% of the information Ieamed whereas the mild 
individual has retained 73%. Consistent with the literature, resuits of analyses 
on rates of forgetting appear to be impacted by the method of evaluation used 
when there are large differences between groups in the amount of information 
Ieamed. This problem has yet to be resolved in the literature. As a result, most 
researchers employ more than one method when analyzing rate of forgetting 
data.
In terms of relationships between the Paragraph and the other verbal tests 
administered in this study, statistically significant positive correlations were 
found in all instances (as predicted) except between the Paragraph and the 
phonemic component of the Verbal Fluency Task (I.e., FAS). Here, the 
correlations were positive (ranging from .34 to .47) but were not statistically 
significant. However, there may be a certain logic to these lower correlations. 
First of all. Paragraph and Verbal Fluency share a verbal component but the 
former is a leaming and memory task whereas the latter is a language test. 
Second, the Paragraph provides a meaningful context for organizing the 
information (i.e., a story line about a brother and sister going to the circus)
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whereas the FAS (unlike the meaningful organizational category of Animals seen 
in semantic fluency), provides only a broad guideline (Tell me as many words 
as you can think of that begin with the letter "F").
Finally, the relationships between the G-LAMB Figure and other 
visuospatial tests in the study were varied. As predicted, a significant, positive 
relationship was found between the G-LAMB Figure and the LAMB Simple 
Figures on leaming and memory trials. Unexpectedly, this was not the case 
between the G-LAMB Figure and LAMB Simple Figures copy trials. With the 
tasks being similar, this difference is difficult to explain. However, it may be a 
statistical artifact whereby the restricted range of scores has depressed the level 
of the correlation. Two other potential explanations involve differences in test 
administration and differences between the figures themselves. First, the 
G-LAMB Figure administration allows for a 30 second exposure to the Figure at 
each leaming trial whereas the LAMB exposure time is only 15 seconds. Thus, 
there may be a different level of familiarity with the figure by the time the copy 
trial is undertaken. A second possible explanation for the lack of a statistically 
significant correlation between the copy trials is that the G-LAMB Figure is one 
discrete unit whereas the LAMB Simple Figures are four distinct figures 
presented in a specific sequence. This difference may have an impact on copy 
performance. For example, those with AD could find copying four figures in a 
specified order more challenging than copying one figure (albeit with more 
detail).
The lack of statistically significant correlations between the G-LAMB
G-LAMB Performance 77
Figure leaming and memory trials and the Clock Test command condition (i.e., 
freehand drawing of a clock) is less surprising because the tasks are somewhat 
different (i.e., the Clock Test does not have traditional leaming or recall 
components). Whether scoring was done using Scale 1 (quantitative score) or 
Scale 2 (qualitative error score), there was a significant relationship between the 
Figure copy trial and the Clock Test command condition. However, although the 
Figure copy trial and the Clock Test copy trial performance were significantly 
correlated when the qualitative error score was calculated (as expected), there 
was no significant relationship when the quantitative score was used. This 
unexpected finding may be due to differences in the degree of familiarity with the 
object being copied (i.e., the G-LAMB Figure is new information whereas the 
face of a clock is not) or differences in test administration (as noted previously). 
Limitations of the Current Studv
Perhaps the most significant limitation to the current study is the small 
sample size. Despite efforts to maximize participation, the final group of fourteen 
participants was below the anticipated participation level. In this regard, two 
main factors need to be taken into account. First, it must be remembered that 
this is the first Alzheimer research in Northem B.C.; therefore, this was a new 
experience for potential participants and their families as well as for local medical 
facilities and agencies. Second, not having an Alzheimer Centre as would be the 
case in a major urban centre meant that participants had to be reached largely 
on an individual basis. Lack of an Alzheimer Centre also meant that there were 
no consistent local criteria for AD diagnosis. Thus, in addition to the G-LAMB, it
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was necessary to conduct other neuropsychological tests in order to ensure that 
participants met the NINCOS-ADRDA diagnostic criteria for probable AO. 
Including these diagnostic tests greatly increased the length of the testing 
procedure and may explain why some participants were unwilling or unable to 
complete the entire process.
Conducting the additional neuropsychological tests also exposed a 
serious weakness in currently available norms. Specifically, for many tests, 
norms are simply unavailable for individuals over the age of 75 years or for those 
who have less than 8 years of education. This is a serious shortcoming when 
attempting to determine whether or not an individual shows a deficit in certain 
skills. Without appropriate age- and education-related norms, particularly for 
those who are older and less educated, it is possible that some people are being 
misidentified (i.e., inappropriately labeled "impaired" or vice versa). When 
assessing the standing of a 92-year-old on a memory test, it can be difficult to 
estimate whether the person shows a deficit when the closest norm available is 
for a 75-year-old and you are left to guess the impact of increased age on that 
skill. The problem is compounded if the 92-year-old has two years of education 
and is being compared to norms for someone with 9 years of schooling. It would 
seem that development of nomns for older and less educated adults is critical to 
future diagnostic evaluation of cognitive deficits.
Future Directions
In general, the Geriatric Leaming and Memory Battery appears to be a 
useful tool for assessing leaming and memory performance in those with
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Alzheimer’s Disease. First, the scores of individuals with Mild AD are high 
enough to allow one to monitor changes in leaming and memory at least into the 
moderate stage of the disease. Second, it was possible to differentiate the 
performance levels of those with Mild and Moderate AD, particularly on the 
Paragraph subtest. However, three immediate tasks remain. First, it would 
seem that development of a less difficult version of the Figure would be helpful in 
order to effect the same high performance level and clear group differentiation 
found with the Paragraph subtest. Second, in order to use the G-LAMB as a 
tracking test, it will be necessary to develop two or three sets of parallel materials 
for use in retest sessions so that practice effects due to the repeated exposure 
of an individual to the same test materials does not contaminate results. Finally, 
having established the utility of the G-LAMB for an AD population, further 
research is needed to evaluate its utility in other clinical populations such as 
those with vascular dementia and brain injuries.
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The purpose of an infonned consent is to ensure that you understand the purpose of the study 
and the nature of your involvement or the involvement of your family member.
Present Study: A Study of Verbal and Vbual Memory
Punwse. The purpose of this study is to examine memory performince for visual and verbal 
information.
Task Requirements. The participant w ill be given several qtportunities to leam and remember a 
short paragraph and a geometric design as well as doing a number of other memory related tasks.
Duration. The testing takes about one and a half hours but this can be divided into two shorter 
sessions if needed.
Anonvmipf/Confidentialitv. The data cdlected in this study w ill be kept confidendai and made 
available only to the researchers associated with this project
Right to Withdraw. Puticipants have the r i^  to refuse to answer any specific question or 
participate in any specific tadt Participants also have the right to withdraw consent and terminate 
participation atanvtime without compromising their right to receive service.
Dissemination of Research Findings. After the research is completed (before the end of 1998). a one 
page summary of the overall results of the study w ill be available to participants and their families 
uponrequesL Individual test results for any stiidy participant w ill ost be made available.
Research Personnel. If  you have any questions, please contact Dawn Hemingway (960-5694) or Dr. 
Anita Hubley (960-6506) at the Universi^  of Northern British Columbia.
1 have read the above description of "A Study of Verbal and Visual Memory” and understand 
the conditions of my participation (or the participation of my family member). My signature 
indicates that I  agree to participate in this study (or to have my family member participate In the 
study).
Participant or Famih Member:
{Print Name) (Signature) (Date)
Consent Obtained bv: PariiÇfPmf’f  Phym m '
(Print Name) (Print Name)
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Appendix B
Map of British Columbia Showing Location of Potential Testing Sites
fDCTSr.JODI
I0KTST.JAM15
N im uia •   ^ vANDnmov
MASnLAKS •  OpRiNCEGEORGEs
P O TgW TlA LTESTIN Q  S ITE S  
(o u ttM * Of P finea O M ig « )
•Bunt Lai» •Mnkoiae
•DtwiooCnek -McEride 
-FL St James -Queamd




FAMILY CONSENT TO RELEASE PHONE NUMBER FOR POTENTIAL RESEARCH PURPOSES
Cumntly, two reseaichen from the Univenity of Nnthera British Cblumbia am studying the usefulness of a 
new test of memoty for people with Alzheitner’s Dtseue (AD). The study, which is funded by the Alzheimer’s Society 
of B.C., is the first of its kiisd to be conducted in nosthem B.C. The lesesichets are looking for people who could 
participate in the study any time between December 1 and Mamh 31.1998. In order to help make this study a success, 
we (PGRCCS) are calling fiunily memfaen of potential participant: in order to obtain permission to provide the 
researchers with your phone number. In this way, you will be able tt> speak directly to the researchers and, on that basis, 
decide if you would lilte your loved one to participate.
Purpose. The purpose of the soidy is to examine the usefiilne» of a new test of verbal and visual memoty for people 
with Alzheimer’s Disease.
Benefits. There ate no immediate benefitt to soidy participants. However, in the long run. it is expected that being able 
to determine the strengths, weaknesses and relative rate of decline in an individual’s verbal and visual memory will 
assist caregivers, both in the community and in care bcilities, to design their interventions more effectively by placing 
mote emphasis on the person’s strength and less on their weaknesses. As a result, a better i)uality of life could be 
provided to persons with cognitive deficits.
Task Requirements. This study examines memory performance for different types of information. The participant will 
be given several opportunities to learn and remeinber a short parapaph and a geometric design as well as doing a 
number of other memory-related tasks.
Duration. The testing takes about one and a half hours but this can be divided into 2 shorter sessions if  needed and can 
be conducted at the cart facility or at the day centre.
Anonvmitv/Confidentialitv. Any data collected in this study will be kept confidential and made available only to the 
researchers associated with this projecL
Riaht to Withdraw. Participants have the right to refuse to answer any specific question or participate in any specific 
task. Participants also have the riaht to withdraw consent and terminate Dartkination at anv time without compromising 
their right to receive service.
Dissemination of Research Findinas. After the research is completed (before the end of 1998), a one page summary of 
the overall results of the study will be available to participants and their families uponrequesL Individual test results for 
any soidy participant will out be made available.
Research Personnel. If  you have any questions, please contact the researchers: Dawn Hemingway at 960-5694 or Dr. 
Anita Hubley at 960^06.
I  understand that giving my consent means that my phone number will be given tt) the soidy researchers so that 
they can contact me directly. 1 also understand that providing my phone number does ngt mean that I have agreed to 
have a family member participate in the study but rather that I  would like to get more information and speak directly to 
the researchers involved
(Name of Family Member) (Date (fonsent Given)
(Name of Resident/Qient) (Facility or Program)
(PGRCCS StaHMemfaer who obtained consent) (Signature of PGRCCS Staff Member)
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Appendix D
Letter to Physicians Regarding Alzheimer Memory Study 
Alzheimer Research In Northem B.C.
December 1997 
Dear Physicians:
We are writing to let you know about a research project, studying the 
usefulness of a new oost-diaonosis memonr test for oeoole with Alzheimer's 
Disease (ADI, that we are currently conducting. The study, which recently 
received some funding from the Alzheimer's Society of B.C., is the first of its kind 
to be conducted in northem B.C.
The main objective of the study is to detemtine if a recently developed 
test, the Geriatric Leaming and Memory Battery (G-LAMB), will be more 
appropriate than traditional memory tests for assessing verbal and visual 
memory in individuals with mild to moderate stage Alzheimer's Disease. 
Traditional memory tests are often too dNfkult and those witti AD may perfomn 
so poorly th^ it is difficult to assess strengths and weaknesses or to track 
memory changes over time.
We expect that the new test will make it possible to better determine the 
strengths, weaknesses and relative rate of decline in the verbal and visual 
memory of an individual already diagnosed with AD. Such infonnation can assist 
physicians and other caregivers, both in the community and in care facilities, by 
placing more emphasis on the person’s strengths and less on their weaknesses. 
We believe that a better understanding of an individual's memory strengths and 
weaknesses can help reduce stress and increase coping abilities for both 
caregivers and persons with AD.
We would appreciate any input or suggestions regarding potential 
participants in the Prince George area. A poster is attached for disolav in vour 
waitino room area. If you require further infonnation, please feel free to call us at 
the numbers listed below.
Sincerely,
Dr. Anita Hubley X  Dawn Hemingway
Assistant Professor, Psychology Master's Student, Psychology




Poster Advertising Alzheimer Memory Study
u f b c
University of Northern 
British Columbia
ALZHEIMER MEMORY STUDY
Have you been recently diagnosed with Alzheimer disease? Do 
yon know anyone who has Alzheimer disease? Dr. Anita Hnhley and 
Dawn Hemingway are conducting a study on learning and memory 
changes in persons with Alzheimer disease In Prince George and other 
northern communities. This is the first time that Alzheimer research 
has been conducted in northern B.C.!
We are looking for as many people as possible with mild to 
modfiEatfijstage Alzheimer disease to take part in this important study. 
Each persou win be givai a numherofdlfferent memory tasks lasting 
approximately 1 % hours. If  desired, this time can be dMded into two 
shorter sessions. Testing can place at the university or in foe 
participant’s home (either in 
foe community or care focfilty).
If  you would like more 
informatiou ahout this 
study (or know anyone 
who might want to take 
part), please call and 
leave a message for 
Dawn Hemingway at 
960-5694 (Memory and 
Aging Laboratory).
Thank you!
ALZHEIMER
MEMORY
STUDY
PARTICIPANTS
NEEDED
Call
960^694
